155 related articles for article (PubMed ID: 32575598)
1. The Effects of MELD-Based Liver Allocation on Patient Survival and Waiting List Mortality in a Country with a Low Donation Rate.
Ritschl PV; Wiering L; Dziodzio T; Jara M; Kruppa J; Schoeneberg U; Raschzok N; Butz F; Globke B; Seika P; Maurer M; Biebl M; Schöning W; Schmelzle M; Sauer IM; Tacke F; Öllinger R; Pratschke J
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32575598
[TBL] [Abstract][Full Text] [Related]
2. [Current developments in liver transplantation in Germany: MELD-based organ allocation and incentives for transplant centres].
Schlitt HJ; Loss M; Scherer MN; Becker T; Jauch KW; Nashan B; Schmidt H; Settmacher U; Rogiers X; Neuhaus P; Strassburg C
Z Gastroenterol; 2011 Jan; 49(1):30-8. PubMed ID: 21225535
[TBL] [Abstract][Full Text] [Related]
3. The MELD system and liver transplant waiting-list mortality in developing countries: lessons learned from São Paulo, Brazil.
Salvalaggio P; Afonso RC; Pereira LA; Ferraz-Neto BH
Einstein (Sao Paulo); 2012; 10(3):278-85. PubMed ID: 23386004
[TBL] [Abstract][Full Text] [Related]
4. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort.
van Vugt JLA; Alferink LJM; Buettner S; Gaspersz MP; Bot D; Darwish Murad S; Feshtali S; van Ooijen PMA; Polak WG; Porte RJ; van Hoek B; van den Berg AP; Metselaar HJ; IJzermans JNM
J Hepatol; 2018 Apr; 68(4):707-714. PubMed ID: 29221886
[TBL] [Abstract][Full Text] [Related]
5. Developments in pediatric liver transplantation since implementation of the new allocation rules in Eurotransplant.
Herden U; Grabhorn E; Briem-Richter A; Ganschow R; Nashan B; Fischer L
Clin Transplant; 2014 Sep; 28(9):1061-8. PubMed ID: 25040668
[TBL] [Abstract][Full Text] [Related]
6. Improved waiting-list outcomes in Argentina after the adoption of a model for end-stage liver disease-based liver allocation policy.
Cejas NG; Villamil FG; Lendoire JC; Tagliafichi V; Lopez A; Krogh DH; Soratti CA; Bisigniano L
Liver Transpl; 2013 Jul; 19(7):711-20. PubMed ID: 23775946
[TBL] [Abstract][Full Text] [Related]
7. Impact of MELD score implementation on liver allocation: experience at a Brazilian center.
da Silva Machado AG; de Medeiros Fleck A; Marroni C; Zanotelli ML; Cantisani G; de Mello Brandão AB
Ann Hepatol; 2013; 12(3):440-7. PubMed ID: 23619261
[TBL] [Abstract][Full Text] [Related]
8. Use of MELD score in country with low organ donation.
Limsrichamrern S; Mahawithitwong P; Sirivatanauksorn Y; Mitmanochai P
J Med Assoc Thai; 2013 Aug; 96(8):924-8. PubMed ID: 23991598
[TBL] [Abstract][Full Text] [Related]
9. Survival on waiting list for liver transplantation before and after introduction of the model for end-stage liver disease score.
Tenório AL; Macedo FI; Miranda LE; Fernandes JL; da Silva CM; Neto OL; Lacerda CM
Transplant Proc; 2010 Mar; 42(2):407-11. PubMed ID: 20304152
[TBL] [Abstract][Full Text] [Related]
10. Consequences of the implementation of the Model for End-stage Liver Disease system for liver allocation in Brazil.
Pestana RC; Baracat EI; Massarollo PC; Pereira LA; Szutan LA
Transplant Proc; 2013; 45(6):2111-4. PubMed ID: 23747144
[TBL] [Abstract][Full Text] [Related]
11. Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality.
Salvalaggio PR; Afonso RC; Pereira LA; Ferraz-Neto BH
Transplant Proc; 2012 Oct; 44(8):2283-5. PubMed ID: 23026574
[TBL] [Abstract][Full Text] [Related]
12. Liver transplantation in Germany.
Tacke F; Kroy DC; Barreiros AP; Neumann UP
Liver Transpl; 2016 Aug; 22(8):1136-42. PubMed ID: 27082951
[TBL] [Abstract][Full Text] [Related]
13. Disparities in Eurotransplant liver transplantation wait-list outcome between patients with and without model for end-stage liver disease exceptions.
Umgelter A; Hapfelmeier A; Kopp W; van Rosmalen M; Rogiers X; Guba M;
Liver Transpl; 2017 Oct; 23(10):1256-1265. PubMed ID: 28650098
[TBL] [Abstract][Full Text] [Related]
14. Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality?
Austin MT; Poulose BK; Ray WA; Arbogast PG; Feurer ID; Pinson CW
Arch Surg; 2007 Nov; 142(11):1079-85. PubMed ID: 18025337
[TBL] [Abstract][Full Text] [Related]
15. Impact of Model for End-stage Liver Disease Score-based Allocation System in Korea: A Nationwide Study.
Lee J; Kim DG; Lee JY; Lee JG; Joo DJ; Kim SI; Kim MS
Transplantation; 2019 Dec; 103(12):2515-2522. PubMed ID: 30985735
[TBL] [Abstract][Full Text] [Related]
16. Liver transplantation for hepatocellular carcinoma: the MELD impact.
Sharma P; Balan V; Hernandez JL; Harper AM; Edwards EB; Rodriguez-Luna H; Byrne T; Vargas HE; Mulligan D; Rakela J; Wiesner RH
Liver Transpl; 2004 Jan; 10(1):36-41. PubMed ID: 14755775
[TBL] [Abstract][Full Text] [Related]
17. Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.
Santori G; Andorno E; Morelli N; Casaccia M; Bottino G; Ghirelli R; Valente U
Transplant Proc; 2008; 40(6):1903-5. PubMed ID: 18675084
[TBL] [Abstract][Full Text] [Related]
18. Re-weighting the model for end-stage liver disease score components.
Sharma P; Schaubel DE; Sima CS; Merion RM; Lok AS
Gastroenterology; 2008 Nov; 135(5):1575-81. PubMed ID: 18835388
[TBL] [Abstract][Full Text] [Related]
19. Experience Since MELD Implementation: How Does the New System Deliver?
Quante M; Benckert C; Thelen A; Jonas S
Int J Hepatol; 2012; 2012():264015. PubMed ID: 23091734
[TBL] [Abstract][Full Text] [Related]
20. Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy.
Wiesner RH; Freeman RB; Mulligan DC
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S261-7. PubMed ID: 15508092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
